D-0514-2019 Class III Terminated
FDA drug recall D-0514-2019 was initiated by ACP Nimble Buyer, Inc. on Feb 7, 2019 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error. The recall status is terminated (terminated Mar 23, 2020). Affected quantity: 58,176 units.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 27, 2019
- Initiation Date
- Feb 7, 2019
- Termination Date
- Mar 23, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 58,176 units
Product description
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37
Reason for recall
Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0514-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026